-

Phibro Animal Health Corporation to Participate in Morgan Stanley Virtual Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Morgan Stanley Virtual Global Healthcare Conference.

Chairman, President and Chief Executive Officer Jack Bendheim, Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and investors on Thursday, September 9, 2021 at 9:30 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will be available and archived on the company’s website.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources. For further information, please visit www.pahc.com.

Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.

Contacts

Damian Finio
Chief Financial Officer, Phibro Animal Health Corporation
+1-201-329-7300
investor.relations@pahc.com

Industry:

Phibro Animal Health Corporation

NASDAQ:PAHC
Release Versions
English

Contacts

Damian Finio
Chief Financial Officer, Phibro Animal Health Corporation
+1-201-329-7300
investor.relations@pahc.com

More News From Phibro Animal Health Corporation

Phibro Animal Health Corporation to Participate in Bank of America 2026 Virtual Animal Health Summit

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2026 Virtual Animal Health Summit. Chief Financial Officer, Glenn David; Chief Operating Officer, Larry Miller and Executive Vice President, Corporate Strategy and CEO designate Daniel Bendheim will address financial analysts and investors on Thursday, February 26, 2026, at 10:45 AM ET. The live audio presentation will be available on the Phibro Animal Healt...

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024): Net sales of $373.9 million, an increase of $64.6 million, or 21% Net income of $27.5 million, an increase of $24.3 million Dil...

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2026, to stockholders of record at the close of business on March 4, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with liv...
Back to Newsroom